Andere talen Shionogi & Co., Ltd.

Aandelen

4507

JP3347200002

Beurs gesloten - Japan Exchange Andere beurzen 08:00:00 27-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
6.256 ^JPY	+0,08%		+2,12%	-7,97%

25/06	Japanse aandelen sluiten hoger nadat ambtenaren zorgen over de volatiliteit van de yen aanpakken	MT
25/06	Shionogi & Co introduceert Covgoze-vaccin voor Covid-19 in Japan	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Japanese Shares Close Higher as Officials Address Yen Volatility Concerns	25/06
Shionogi & Co Introduces Covgoze Vaccine for Covid-19 in Japan	25/06
Shionogi & Co. to Dispose of 450 Million Yen Worth of Shares as Restricted Stock Compensation	21/06
Shionogi & Co., Ltd. - Option Agreement with Cilcare for Development Compounds Addressing Hearing Loss	07/06
Japan's Nikkei little changed ahead of key US data, central bank meetings	07/06
Japan's Nikkei edges down ahead of key US data, central bank meetings	07/06
Shionogi Expands Global Infectious Disease and Antimicrobial Research Operations to U.S. to Address Current and Emerging Health Threats	05/06
Shionogi & Co., Ltd. - Launch of the Gram-negative Bacterial Infection Treatment FETROJA 1g, in Taiwan	29/05
Japan's Nikkei drifts sideways as more earnings, US CPI awaited	14/05
Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe Disease	13/05
MÄRKTE ASIEN/Börsen wenig verändert - Mazda sehr schwach	13/05
MÄRKTE ASIEN/Uneinheitlich - Anleger meiden Risiken vor US-Preisdaten	13/05
Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial	13/05
Shionogi - Notice of Collaboration Agreement for the Discovery and Development of Novel Malaria Preventive Drugs with Nagasaki University, National Institute of Infectious Diseases, and MMV, Supported by the GHIT Fund	09/05
Akili, Inc. Announces an Amendment to its Strategic Distribution Agreement with Shionogi & Co., Ltd	30/04
Shionogi & Co., Ltd. Revises Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024	25/04
Shionogi & Co., Ltd. - Notice regarding introduction of a Restricted Stock Compensation Plan for Vice Presidents	23/04
Shionogi & Co., Ltd. - Notice Regarding Completion of Cancellation of Treasury Shares	19/04
ESCMID Global 2024, Shionogi presents real-world data demonstrating efficacy of Fetcroja, Fetroja in critically ill patients with certain difficult-to-treat bacterial infections	19/04
Shionogi & Co Completes Cancellation of 10.84 Million Treasury Shares	19/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Shionogi & Co., Ltd.

Aandelen

4507

JP3347200002

Andere talen

Filters